Arcadia Investment Management Corp MI Sells 367 Shares of Danaher Co. (NYSE:DHR)

Arcadia Investment Management Corp MI decreased its stake in shares of Danaher Co. (NYSE:DHR) by 3.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 11,636 shares of the conglomerate’s stock after selling 367 shares during the quarter. Arcadia Investment Management Corp MI’s holdings in Danaher were worth $2,671,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. AMF Tjanstepension AB bought a new stake in Danaher in the third quarter valued at about $5,923,000. Howard Capital Management Group LLC increased its stake in Danaher by 4.1% in the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after acquiring an additional 48 shares during the period. Foundations Investment Advisors LLC increased its stake in Danaher by 5.3% in the third quarter. Foundations Investment Advisors LLC now owns 1,637 shares of the conglomerate’s stock valued at $455,000 after acquiring an additional 82 shares during the period. Private Advisor Group LLC increased its stake in Danaher by 5.6% in the third quarter. Private Advisor Group LLC now owns 45,631 shares of the conglomerate’s stock valued at $12,686,000 after acquiring an additional 2,431 shares during the period. Finally, International Assets Investment Management LLC increased its stake in Danaher by 40,196.5% in the third quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock valued at $119,539,000 after acquiring an additional 428,897 shares during the period. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of DHR stock opened at $208.10 on Friday. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70. The firm’s 50 day moving average is $227.21 and its 200-day moving average is $247.52. The firm has a market capitalization of $150.31 billion, a price-to-earnings ratio of 39.41, a PEG ratio of 2.61 and a beta of 0.83. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the prior year, the business earned $2.09 earnings per share. Sell-side analysts forecast that Danaher Co. will post 7.67 EPS for the current fiscal year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.62%. This is an increase from Danaher’s previous quarterly dividend of $0.27. Danaher’s payout ratio is 20.45%.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on DHR. Royal Bank of Canada reissued an “outperform” rating and issued a $277.00 target price (down previously from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Wolfe Research upgraded shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target on the stock in a research report on Thursday, October 31st. Wells Fargo & Company reduced their price target on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Barclays reduced their price target on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Finally, Raymond James restated a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

Insider Buying and Selling

In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 11.10% of the stock is currently owned by insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.